PTO Application Changes To Hit Bio, Pharma Hardest
The change, which would limit a patent application to a single continuation, is one of many approaches the embattled USPTO is making to reduce its staggering backlog of applications. Like many other proposed changes, it could also have the added benefit of reducing legal disputes.
According to the Federal Trade...
To view the full article, register now.